drugset / Trial / NCT00245908

ASTHMA (AntibioticS To Help Manage Asthma) Pilot Study

NCT00245908

Phase 3 Completed 100 enrolled Wisconsin Research Network
RandomizedParallel-groupDouble-blindTreatment

Summary

The ASTHMA Pilot Study is a randomized, controlled, parallel group clinical trial of 6 weekly doses of azithromycin (cumulative dose 4800 mg) or placebo as adjunctive treatment in addition to usual care for adults with stable persistent asthma, with final follow up at 3 months after completion of study medication. The hypothesis to be tested is that antibiotic treatment will improve asthma at followup, and that this improvement will be limited to patients with evidence of C. pneumoniae infection. The secondary hypothesis is that randomized, controlled treatment trials can be carried out successfully in a geographically dispersed practice-based research network.

Timeline

Start
1999-09
Primary completion
Completion
2002-09

Drugs

EvaluationDrugModalityDoseRoute
Subject Azithromycin Small molecule 800 mg

Indications